BioMarin Pharmaceutical Inc. (BMRN) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)

BioMarin Pharmaceutical(US:BMRN) Seeking Alpha·2025-09-04 15:27

Group 1 - The session features Mohit Bansal, a Senior Equity Analyst at Wells Fargo, who specializes in biotech and pharma [1] - Greg Friberg, the EVP and Chief Research and Development Officer at BioMarin, is present for the discussion [1]